Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis

To compare the cost of two patient management strategies with similar efficacies for chronic inflammatory demyelinating polyneuropathy (CIDP) patients in the chronic phase: hospital-based IV immunoglobulin G (IVIg) and home-based subcutaneous immunoglobulin G (SCIg) associated with an interprofessio...

Full description

Saved in:

Bibliographic Details
Published in:	PloS one Vol. 15; no. 11; p. e0242630
Main Authors:	Perraudin, Clémence, Bourdin, Aline, Vicino, Alex, Kuntzer, Thierry, Bugnon, Olivier, Berger, Jérôme
Format:	Journal Article
Language:	English
Published:	United States Public Library of Science 25.11.2020 Public Library of Science (PLoS)
Subjects:	Analysis Biology and Life Sciences Chemotherapy Cost analysis Cost-Benefit Analysis Costs Demyelinating diseases Demyelination Drug dosages Drug therapy Economic aspects Health care costs Health insurance Home Care Services - economics Hospitals Humans IgG antibody Immunoglobulin G Immunoglobulins Immunoglobulins, Intravenous - administration & dosage Immunoglobulins, Intravenous - economics Inflammation Infusions, Subcutaneous Insurance Intravenous administration Intravenous immunoglobulins Maintenance Medication Therapy Management - economics Medicine and Health Sciences Neurosciences Optimization Patients People and Places Pharmaceutical sciences Pharmacy Polyneuropathies Polyneuropathy Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - economics Primary care Professionals Public health Social Sciences Switzerland Training Switzerland United States > US
ISSN:	1932-6203, 1932-6203
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!